Reagent Kit for Determining Genetic Polymorphisms Associated with Clopidogrel Metabolism by Real-Time PCR (PharmacoGenetics Clopidogrel) according to TU 9398-043-46482062-2015

Reagent Kit for Determining Genetic Polymorphisms Associated with Clopidogrel Metabolism by Real-Time PCR (PharmacoGenetics Clopidogrel) according to TU 9398-043-46482062-2015

The "PharmacoGenetics Clopidogrel" reagent kit is designed for determining genetic polymorphisms associated with the metabolism of clopidogrel using real-time PCR. It complies with TU 9398-043-46482062-2015.

Kit Composition

• Amplification Mixtures (4 types):
  • ABCB1: 3435 C>T – 1 tube (960 μl)
  • CYP2C19: 681 G>A*2 (R227R) – 1 tube (960 μl)
  • CYP2C19: 636 G>A*3 (W212X) – 1 tube (960 μl)
  • CYP2C19: -806 C>T*17 – 1 tube (960 μl)
• Polymerase: TechnoTaq MAX – 1 tube (100 μl)
• PCR Buffer: 2 tubes, 1 ml each
• Mineral Oil: 4 tubes, 1 ml each
• Control Samples:
  • Control Sample (Common Homozygote) – 1 tube (240 μl)
  • Control Sample (Rare Homozygote) – 1 tube (240 μl)

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Determining Genetic Polymorphisms Associated with Clopidogrel Metabolism by Real-Time PCR (PharmacoGenetics Clopidogrel) according to TU 9398-043-46482062-2015, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.